2020
DOI: 10.1038/s41582-020-0355-1
|View full text |Cite
|
Sign up to set email alerts
|

Treatment and management of cognitive dysfunction in patients with multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
110
0
12

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 141 publications
(126 citation statements)
references
References 203 publications
4
110
0
12
Order By: Relevance
“…The assessment of cognitive functions is becoming a cornerstone in routine clinical care and clinical trials of MS patients [1,3,5]. Especially with regard to the inclusion of cognitive tests in clinical trials, it is essential that the tests are reliable and quickly administrable.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The assessment of cognitive functions is becoming a cornerstone in routine clinical care and clinical trials of MS patients [1,3,5]. Especially with regard to the inclusion of cognitive tests in clinical trials, it is essential that the tests are reliable and quickly administrable.…”
Section: Discussionmentioning
confidence: 99%
“…Cognitive dysfunctions are a frequent concomitant of Multiple Sclerosis (MS) with a prevalence of 40 to 70% [1,2]. The assessment of cognitive dysfunctions in MS is therefore central to the characterization and staging of the disease [1,[3][4][5], which leads to the definition of specific MS phenotypes [6]. Several cognitive screening batteries have been developed.…”
Section: Introductionmentioning
confidence: 99%
“…A further problem is that many everyday situations do not only claim a circumscribed executive function but represent a mixture of different processes. For this reason, cognitive testing using common neuropsychological tests often falls short ( 1 , 6 ). Most day-to-day requirements demand several aspects of executive functions simultaneously or in rapid succession.…”
Section: Cognitive–cognitive Dual Tasking Assessment In the Context Omentioning
confidence: 99%
“…Cognitive impairment is prevalent at all phases and all subtypes of multiple sclerosis (MS). It remains one of the major causes of neurological disability in young and middle-aged adults suffering from the disease ( 1 ). The severity and the type of cognitive impairment vary considerably among individuals and can be observed both in early and in later stages.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation